Sort
130,381 grants matching “hiv”
Cocaine use, viral suppression and precursors of stroke in HIV infection
$807,263Elise D Riley · University Of California, San Francisco · R01 · FY2023 · DA
Advancing Multi-bNAbs Microneedle Patch Technology For HIV-1 Prevention in Breastfeeding Infants.
$807,257Gustavo F. Doncel · Old Dominion University · R01 · FY2024 · AI
Characterization of CAR-directed T-cells to suppress HIV-1 in vivo
$807,216Scott G Kitchen · University Of California Los Angeles · U19 · FY2019 · AI
Effect of immunization route and prior immunity for a live attenuated varicella AIDS vaccine
$807,124Vicki L Traina-Dorge · Tulane University Of Louisiana · R01 · FY2017 · AI
Translational research to increase service access for NYS juvenile probationers
$807,104Gail A Wasserman · Columbia University Health Sciences · U01 · FY2013 · DA
Targeting PD-1 Pathway for Functional Cure of AIDS
$807,098Rama Rao Amara · Emory University · R37 · FY2023 · AI
Technology Based Community Health Nursing to Improve cART Adherence and Virologic Suppression in Youth Living with HIV (TechN 2 CheckIN): A Regional Multi-site Study
$807,092Allison L Agwu · Johns Hopkins University · R01 · FY2019 · MD
Expertise in Using Bitter Taste Receptor Blockers to Improve the Palatability of Pediatric Medicines: Trained Human Sensory Panels
$807,060Peter Silvera · Advanced Bioscience Laboratories, Inc. · N01 · FY2024 · AI
HIV DISEASE OUTCOMES IN DRUG USERS IN CLINICAL PRACTICE
$807,007Johns Hopkins University · R01 · FY2001 · DA
Fine Mechanisms of Adaptive NK Cell Formation Against HIV and SIV
$806,931Roger Keith Reeves · Duke University · R01 · FY2024 · AI
Design Of Immunogens
$806,920Peter D Kwong · National Institute Of Allergy And Infectious Diseases · ZIA · FY2010 · AI
Host blood biomarkers for the diagnosis prognosis and treatment response of childhood TB
$806,919Mark Hatherill · University Of Cape Town · R01 · FY2024 · AI
Cost-Effectiveness of Preventing HIV Complications
$806,891Kenneth Alan Freedberg · Massachusetts General Hospital · R01 · FY2021 · AI
The National Drug Abuse Treatment Clinical Trials Network
$806,857Roger D. Weiss · Mclean Hospital · UG1 · FY2016 · DA
Administrative Core
$806,810Jane Marie Simoni · University Of Washington · P30 · FY2024 · MH
Maintenance of the SPF Breeding Colonies at Yerkes National Primate Research Center: Husbandry and Management Core
$806,750Joyce Kimberly Cohen · Emory University · U42 · FY2019 · OD
Early Detection Research Network: Clinical Validation of Molecular Signatures of
$806,636National Cancer Institute · Y01 · FY2009 · CA
Chemoprophylaxis and HIV-Host Interactions
$806,636Robert M. Grant · J. David Gladstone Institutes · R01 · FY2007 · AI
WADA (West Africa Database on Antiretroviral Therapy) Collaboration
$806,578Francois Dabis · University Of Bordeaux Ii · U01 · FY2006 · AI
Glycomic Modulation of Gut Microbiome During HIV Infection
$806,565Mohamed Abdel Mohsen · Wistar Institute · R01 · FY2021 · DK
Pharmacogenomics of HIV Therapy
$806,550David W Haas · Vanderbilt University Medical Center · R01 · FY2025 · AI
Lung Microbiome in Cohorts of HIV-Infected Persons (Lung MicroCHIP) Study
$806,464Laurence Huang · University Of California, San Francisco · U01 · FY2009 · HL
Early Predictors of Child and Adolescent Substance Use
$806,434Judy A Andrews · Oregon Research Institute · R01 · FY2006 · DA
A Type 1 Hybrid Effectiveness-Implementation Evaluation of a City-Level Transitional Housing Program's Effects on Health, Economic, and Psychologic Outcomes Among People with HIV
$806,431Aaron G Richterman · University Of Pennsylvania · U01 · FY2024 · NR
Host genetic predictors of plasma IL-1b levels and pharmacogenomics of in vivo IL-1b blockade during treated HIV disease
$806,398Sulggi Angela Lee · University Of California, San Francisco · R01 · FY2023 · AI